These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 658781)

  • 1. Changes in plasma levels of prekallikrein, kallikrein, high molecular weight kininogen and kallikrein inhibitors during lethal endotoxin shock in dogs.
    Gallimore MJ; Aasen AO; Amundsen E
    Haemostasis; 1978; 7(2-3):79-84. PubMed ID: 658781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Falls in plasma levels of prekallikrein, high molecular weight kininogen, and kallikrein inhibitors during lethal endotoxin shock in dogs.
    Gallimore MJ; Aasen AO; Lyngaas KH; Larsbraaten M; Amundsen E
    Thromb Res; 1978 Feb; 12(2):307-18. PubMed ID: 565085
    [No Abstract]   [Full Text] [Related]  

  • 3. High and low molecular weight kininogen and plasma prekallikrein/plasma kallikrein in villous capillaries of human term placenta.
    Hermann A; Buchinger P; Somlev B; Rehbock J
    Placenta; 1996 May; 17(4):223-30. PubMed ID: 8761966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of a cationic fragment of high molecular mass kininogen and effect of this fragment on human plasma kallikrein activity.
    Yarovaya GA; Dotsenko VL; Orekhovich VN
    Clin Chim Acta; 1982 Aug; 123(3):261-7. PubMed ID: 6922013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma kallikrein activity and prekallikrein levels during endotoxin shock in dogs.
    Aasen AO; Frolich W; Saugstad OD; Amundsen E
    Eur Surg Res; 1978; 10(1):50-62. PubMed ID: 344043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human plasma prekallikrein and high molecular weight kininogen decrease during parturition.
    Alving BM; Niebyl JR; Proud D; Mason BL; Pisano JJ
    Thromb Res; 1984 Jun; 34(6):473-7. PubMed ID: 6564799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assay methods for prekallikrein and kininogens and their applications.
    Uchida Y; Ohishi S; Tanaka K; Harada Y; Ueno A; Katori M; Funahashi S; Hashimoto T; Ueno T; Kodama J
    Adv Exp Med Biol; 1979; 120A():173-84. PubMed ID: 495307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dynamics of components of the kallikrein-kinin system in the arterial and venous blood and cerebrospinal fluid of patients with severe cranio-cerebral injuries].
    Valeev IK; Raĭzman SM; Tsibul'kin AP
    Zh Vopr Neirokhir Im N N Burdenko; 1979; (1):27-30. PubMed ID: 425774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the kallikrein kinin system during acute pancreatitis in man.
    Lasson A; Ohlsson K
    Thromb Res; 1984 Jul; 35(1):27-41. PubMed ID: 6206588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kallikrein-kinin system in severe experimental hypertension.
    Quadra JA; Bossolan D; Stella RC; Ribeiro AB; Kohlmann O; Ramos OL
    Adv Exp Med Biol; 1986; 198 Pt B():313-9. PubMed ID: 3643729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma prekallikrein, kallikrein inhibitors, kininogen and lipids during gemfibrozil treatment in type II dyslipidaemia.
    Torstila I; Kaukola S; Manninen V; Virtamo J; Mälkönen M
    Acta Med Scand Suppl; 1982; 668():123-9. PubMed ID: 6188330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parallel mechanisms of high molecular weight kininogen action as a cofactor in kallikrein inactivation and prekallikrein activation reactions.
    Olson ST; Francis AM; Sheffer R; Choay J
    Biochemistry; 1993 Nov; 32(45):12148-59. PubMed ID: 8218292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in prekallikrein and high molecular weight kininogen levels in two strains of Brown Norway rat (Kitasato strain and Katholiek strain).
    Oh-ishi S; Satoh K; Hayashi I; Yamazaki K; Nakano T
    Thromb Res; 1982 Oct; 28(1):143-7. PubMed ID: 6925403
    [No Abstract]   [Full Text] [Related]  

  • 15. Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma.
    Scott CF; Colman RW
    J Clin Invest; 1980 Feb; 65(2):413-21. PubMed ID: 7356688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinin activation and protease inhibitors in acute pancreatitis in man.
    Lasson A; Ohlsson K
    Adv Exp Med Biol; 1986; 198 Pt B():423-32. PubMed ID: 2433917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.
    Olson ST; Sheffer R; Francis AM
    Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.
    Aasen AO; Erichsen NS; Gallimore MJ; Amundsen E
    Adv Shock Res; 1980; 4():1-10. PubMed ID: 6172027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.
    Donaldson VH; Kleniewski J; Saito H; Sayed JK
    J Clin Invest; 1977 Sep; 60(3):571-83. PubMed ID: 893663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tachibana trait: human high molecular weight kininogen deficiency with diminished levels of prekallikrein and low molecular weight kininogen.
    Nakamura K; Iijima K; Fukuda C; Kadowaki H; Ikoma H; Oh-ishi S; Uchida Y; Katori M
    Nihon Ketsueki Gakkai Zasshi; 1985 Sep; 48(6):1473-9. PubMed ID: 3853954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.